These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36162491)

  • 1. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
    García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
    Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
    García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
    Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
    García-Martínez FJ; Hernández-Martín A
    Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
    Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
    J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
    Yao R; Wang L; Yu Y; Wang J; Shen Y
    J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hallazgos clínicos y epidemiológicos en la neurofibromatosis tipo 1 y el complejo esclerosis tuberosa en una serie de pacientes pediátricos].
    Cammarata-Scalisi F; Stock F; Velazco N; Silva GD; Lacruz-Rengel MA; Avendaño A
    Bol Med Hosp Infant Mex; 2018; 75(5):287-294. PubMed ID: 30250319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
    Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
    JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic diagnosis of a child with Café-au-lait macules and juvenile xanthogranuloma].
    Lu X; Xiao F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1266-1269. PubMed ID: 36317216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
    Cambiaghi S; Restano L; Caputo R
    Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
    Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
    J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiomatous and cerulodermic macules: early cutaneous signs of neurofibromatosis type I].
    Vabres P; de Lonlay P; Amiel J; Lyonnet S; Munnich A; de Prost Y
    Ann Dermatol Venereol; 1998 Sep; 125(9):593-4. PubMed ID: 9805547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1.
    Vázquez-Osorio I; Duat-Rodríguez A; García-Martínez FJ; Torrelo A; Noguera-Morel L; Hernández-Martín A
    Pediatr Dermatol; 2017 May; 34(3):271-276. PubMed ID: 28318056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Café-au-lait Macules and their Association with the Neurofibromatosis type I Genotype in a Cohort of Greek Children.
    Nasi L; Alexopoulos A; Kokkinou E; Roka K; Tzetis M; Tsipi M; Kakourou T; Kanaka-Gantenbein C; Chrousos G; Kattamis A; Pons R;
    Acta Derm Venereol; 2023 Jun; 103():adv5758. PubMed ID: 37272364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations in neurofibromatosis type 1.
    Miraglia E; Moliterni E; Iacovino C; Roberti V; Laghi A; Moramarco A; Giustini S
    Clin Ter; 2020; 171(5):e371-e377. PubMed ID: 32901776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.
    Raygada M; Arthur DC; Wayne AS; Rennert OM; Toretsky JA; Stratakis CA
    Pediatr Blood Cancer; 2010 Jan; 54(1):173-5. PubMed ID: 19785027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.